Genomic organization and promoter function of the human thyrotropin-releasing hormone receptor gene

Genomic organization and promoter function of the human thyrotropin-releasing hormone receptor gene
复制标题

DOI:
10.1074/jbc.271.36.22183
复制
发表时间:
1996-09-06
影响因子:
4.8
通讯作者:
Mori, M
Mori, M
中科院分区:
生物学2区
文献类型:
--
作者:
Iwasaki, T;Yamada, M;Mori, M

文献摘要

被引文献

相似文献

我们分离并鉴定了人促甲状腺激素释放激素受体基因,该基因全长30kb,包含3个外显子和2个内含子,内含子1存在于5‘-非翻译区,内含子2长度超过25kb,在推测的第六跨膜结构域开始之前中断了编码区。外显子3编码编码区的其余部分和整个3‘-非翻译区。3‘-侧翼区含有4个潜在的多聚腺苷酸化信号,3’-末端快速扩增研究表明,只有终止密码子下游2076个碱基对的信号在垂体前叶起作用,引物延伸和锚定-聚合酶链式反应研究表明,在翻译起始点上游的344个碱基对上有一个转录起始点,启动子区域在适当的位置既不包含TATA盒,也不包含CAAT盒。瞬时转染研究表明,启动子在GH4C1细胞中具有显著的活性,转录起始点-338--933bp之间的区域起负调控作用。对促甲状腺激素释放激素(TRH)受体基因的基因组结构和启动子区域的了解将有助于进一步研究TRH受体可能的紊乱,并有助于阐明人类TRH受体基因的转录调控。
We isolated and characterized the gene for the human thyrotropin-releasing hormone receptor, The gene spanned more than 30 kilobases and contained three exons and two introns, Intron 1 exists in the 5'-untranslated region, and intron 2 is more than 25 kilobases in length which interrupts the coding region before the beginning of the putative sixth transmembrane domain. Exon 3 encodes the rest of the coding region and the entire 3'-untranslated region. The 3'-flanking region contains four potential polyadenylation signals, and 3'-rapid amplification of cDNA ends studies showed that only a signal at 2076 base pairs downstream of the stop codon was functional in the anterior pituitary, Primer extension and anchor-polymerase chain reaction studies indicated a transcriptional start site at 344 base pairs upstream of the translational start site, The promoter region does not contain either a TATA box or a CAAT box in the appropriate location, Transient transfection study revealed significant activity of the promoter in GH4C1 cells, and the region between -338 and -933 bp from the transcriptional start site worked as a negative regulator, Knowledge of the genomic organization and the promoter region of thyrotropin-releasing hormone (TRH) receptor gene will allow further studies of possible disorders of the TRH receptor, as well as facilitate elucidation of transcriptional control of the human TRH receptor gene.